» Authors » Laetitia Languille

Laetitia Languille

Explore the profile of Laetitia Languille including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 28
Citations 657
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Larue M, Moulis G, Rueter M, Audia S, Terriou L, Viallard J, et al.
Blood Adv . 2025 Jan; PMID: 39874521
To assess efficacy and safety of dapsone in adult immune thrombocytopenia (ITP), a multicenter randomized controlled trial (RCT) and a real-word study cohort were performed. Participants were adults with primary...
2.
Cottu A, Guillet S, Viallard J, Riviere E, Cheze S, Gobert D, et al.
Blood . 2024 Oct; 145(2):244-247. PMID: 39476101
In an open prospective, multicenter study enrolling 48 selected patients with chronic immune thrombocytopenia who achieved complete response for 1 year on thrombopoietin receptor agonists, half of the patients maintained...
3.
Dubois S, Layese R, Limal N, Languille L, Kini-Matondo W, Mahevas M, et al.
Br J Haematol . 2024 Oct; 205(6):2425-2431. PMID: 39389921
Intravenous immunoglobulin (IVIg) is the gold standard treatment for severe cases of immune thrombocytopenia (ITP). However, its cost, limited duration of efficacy and market supply tension have led French guidelines...
4.
Manfroi B, Cuc B, Sokal A, Vandenberghe A, Temmam S, Attia M, et al.
Sci Transl Med . 2024 Sep; 16(765):eadl1997. PMID: 39292802
The development of the human immune system lasts for several years after birth. The impact of this maturation phase on the quality of adaptive immunity and the acquisition of immunological...
5.
Sokal A, Barba-Spaeth G, Hunault L, Fernandez I, Broketa M, Meola A, et al.
Immunity . 2023 Aug; 56(9):2137-2151.e7. PMID: 37543032
How infection by a viral variant showing antigenic drift impacts a preformed mature human memory B cell (MBC) repertoire remains an open question. Here, we studied the MBC response up...
6.
Sorin B, Gaigne L, Garzaro M, Moulis G, Mageau A, Lopez C, et al.
Am J Hematol . 2023 Jul; 98(9):E259-E262. PMID: 37410544
No abstract available.
7.
Broketa M, Sokal A, Mor M, Canales-Herrerias P, Perima A, Meola A, et al.
JCI Insight . 2023 May; 8(13). PMID: 37252802
SARS-CoV-2 mRNA vaccination generates protective B cell responses targeting the SARS-CoV-2 spike glycoprotein. Whereas anti-spike memory B cell responses are long lasting, the anti-spike humoral antibody response progressively wanes, making...
8.
Guillet S, Crickx E, Azzaoui I, Chappert P, Boutin E, Viallard J, et al.
Blood . 2023 Mar; 141(23):2867-2877. PMID: 36893453
Sustained response off treatment (SROT) after thrombopoietin receptor agonist (TPO-RA) discontinuation has been reported in immune thrombocytopenia (ITP). This prospective multicenter interventional study enrolled adults with persistent or chronic primary...
9.
Sokal A, Bastard P, Chappert P, Barba-Spaeth G, Fourati S, Vanderberghe A, et al.
J Exp Med . 2022 Nov; 220(1). PMID: 36342455
Inborn and acquired deficits of type I interferon (IFN) immunity predispose to life-threatening COVID-19 pneumonia. We longitudinally profiled the B cell response to mRNA vaccination in SARS-CoV-2 naive patients with...
10.
Sokal A, Broketa M, Barba-Spaeth G, Meola A, Fernandez I, Fourati S, et al.
Immunity . 2022 Apr; 55(6):1096-1104.e4. PMID: 35483354
The SARS-CoV-2 Omicron variant can escape neutralization by vaccine-elicited and convalescent antibodies. Memory B cells (MBCs) represent another layer of protection against SARS-CoV-2, as they persist after infection and vaccination...